We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Science Group Plc | LSE:SAG | London | Ordinary Share | GB00B39GTJ17 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 407.00 | 390.00 | 414.00 | - | 0.00 | 07:43:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Consulting Svcs,nec | 98.82M | 10.56M | 0.2322 | 17.53 | 185.02M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/11/2011 07:29 | Truffle - see the 'ZULU' thread . . . . . . Based on the book 'The Zulu Principle' by Jim Slater. | bigbigdave | |
07/11/2011 07:27 | In simple terms, what is a ZULU anyone? TIA. | truffle | |
06/11/2011 16:22 | Some good posts to go with the solid support Friday. I feel more than ever that something is brewing here Numis and Sphere aside. | hastings | |
06/11/2011 14:47 | The PEG rule is a good one but if you wait for 5 years earnings growth you often find the the shareprice has re-rated to a much higher PE. With zulus, if you can spot them in their more embriolic stage you stand to gain far more by the time thet have that record. It does add to your risk tho as earnings are obviosly less assured from businesses with less of a growth record. Depends on your risk profile imo. CR | cockneyrebel | |
06/11/2011 14:25 | Must remember that Jim Slater revised his rules in 'Beyond' and hence. A 5yr track record is no longer mandatory to classify as a Zulu. Just two year of historic growth combined with two years of forecast growth is enough to gain a PEG factor and hence to class as a Zulu. Im even more relaxed than that with my rules. Even one year of historic growth combined with 3 years of forecast growth would classify as a Zulu under my own personal rules. I think one has to apply commonsense. If its pretty obvious that a share will class as a Zulu in a couple of years by having that 5 year track record or PEG, then why not just assume it is one now!? Or course, not all things go exactly to plan but i do think that some are more obvious than others. Emphasis is on 'prospective' or 'provisional' PEG when you have these kinds of instances. | cfro | |
05/11/2011 21:53 | cfro - we had a discussion a few days back on CR's thread about the possibilities of SAG becoming a Zulu further down the line. As I said on there JS says that 5yrs earnings growth can be reduced if there is an obvious reason for the sudden growth increase and clarity that it will remain. I think the change in management along with the change in how SAG makes its money gives us just that. Also you make a good point regarding the US exposure, that market is massive and aside from the emerging markets that is likely to grow faster than most and certainly faster than the UK or European markets. | greenroom78 | |
05/11/2011 12:19 | I like how Brent Hudson sums up the interview. "The available market for Sagentia is huge," he believes, "and we are only really scratching the surface. Whether the growth is organic or comes through acquisitions, it's a hugely exciting time," he concluded. CR, You are spot on to point out the PBT increase, which highlights the dilution last year. Interims 2010 = 25,479m shares used to calulate EPS, against 41,723m for 2011. And they still increased EPS by 22% to 4.9p. No more dilution from now on, so EPS growth should increase strongly now. Forecast for full year is 7.4p is very conservative imv, when you consider not only the end of the dilution, but also the £10.m 3 year contract announced 29th September. Plenty of room for an ahead trading update imo. ic2... | interceptor2 | |
05/11/2011 11:41 | Good article interceptor2. One important thing that most of these articles don't highlight isd the change in business model. They used to take stakes in these co's that they do R&D for and a lot of their gains came when that co floated. Great if that was successful but not so good if th co flopped. The new model means they get paid for doing R&D. Most co's are good at inventing things but not taking them to market necessarily - SAG do that for them. I suspect most peoople are looking at the earnings growth but that betrays the real performance imo as there was dilution last year. Look at the pre-tax profit. These are now working on much higher margins. Sales were up 22% in H1 while profits more than doubled at 114% Cash grew by £5m over H1 last year to £17m. With SAG doing R&D I'm not sure how they are affected by SME R&D relief as they do R&D for other companies and who can claim what under this relief. But I suspect SAG will see very beneficial tax rates going forward as their turnover is well under the 100m Euro revenues limit to qualify. CR | cockneyrebel | |
04/11/2011 22:23 | I brought more today on the break up. The link below is a recent interview with the CEO which gives a feel for what SAG is about. ic2... | interceptor2 | |
04/11/2011 19:50 | Here's the website cfro: This link posted by hastings above will help you too: CR | cockneyrebel | |
04/11/2011 18:36 | Noticed the share price rising fast the couple of days, so bit the bullet today and bought an initial stake of 5000 shares. Problem is, i gotta admit im clueless as to what the co actually does....so i had better run along and do some research! :0)) | cfro | |
04/11/2011 18:33 | Noticed the share price rising fast the couple of days, so bit the bullet today and bought an initial stake of 5000 shares. Problem is, i gotta admit im clueless as to what the co actually does....so i had better run along and do some research! :0)) | cfro | |
04/11/2011 14:58 | A late reported 28k @90.5p as well. | greenroom78 | |
04/11/2011 14:29 | Sphere Medical floats by Friday next week - 7% owned by SAG - should be interesting to see what it floats at. I think SAG will sell their stake at an early opportunity. CR | cockneyrebel | |
04/11/2011 14:16 | Numis note I would guess. Wouldn't they get their clients on board before issuing the note? | greenroom78 | |
04/11/2011 13:59 | 25k buy after yesterday's 50k - bit of news coming? CR | cockneyrebel | |
04/11/2011 12:04 | Mmm CR stepping on the gas!! | hastings | |
04/11/2011 10:40 | Making new highs today :-) CR | cockneyrebel | |
04/11/2011 08:05 | Perhaps we will see a few more big feet wading in today ! | hastings | |
03/11/2011 17:37 | Confident buy when you think they paid pretty much the highest price of the year (and ever?) - 50k is not dipping a toe in either (unless you've got very big feet!). | greenroom78 | |
03/11/2011 17:08 | Yes would appear to be what moved it up. Should be interesting to see if there are any follow ups of a similar size. | hastings | |
03/11/2011 17:06 | I wonder if that is what caused the tick up, there was no trade at the time it moved. Confident buy none the less. | greenroom78 | |
03/11/2011 17:03 | And a decent Buy this pm 50k @89p | hastings | |
03/11/2011 15:23 | Brent Hudson has brought in quality Directors who would bring plenty of experience in handling acquisitions. As well as the Chairman who joined in April 2010 with historic positions with Microgen and Dell. Look at the FD Neil Elton who joined in August 2010, and was FD at Concateno (Medical Testing company) which was taken over June 2010. As well as organic growth, they mainly grew by making many excellent acquisitions before they were taken over themselves. Strong management has always been an attraction for me with SAG, and what they might do with such a strong balance sheet. ic2... | interceptor2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions